X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1042) 1042
Publication (130) 130
Book Chapter (32) 32
Book Review (32) 32
Book / eBook (11) 11
Newsletter (3) 3
Conference Proceeding (1) 1
Government Document (1) 1
Magazine Article (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (856) 856
hematology (585) 585
index medicus (573) 573
female (505) 505
male (501) 501
middle aged (427) 427
adult (366) 366
aged (362) 362
myeloproliferative disorders (359) 359
oncology (340) 340
essential thrombocythemia (302) 302
polycythemia-vera (294) 294
mutation (256) 256
prognosis (238) 238
aged, 80 and over (214) 214
leukemia (206) 206
myelofibrosis (206) 206
myeloproliferative neoplasms (195) 195
risk factors (195) 195
myeloproliferative disorders - mortality (170) 170
retrospective studies (154) 154
adolescent (151) 151
myeloproliferative disorders - genetics (151) 151
janus kinase 2 - genetics (143) 143
thrombosis (143) 143
research (127) 127
care and treatment (126) 126
treatment outcome (125) 125
survival analysis (124) 124
polycythemia vera (120) 120
myeloproliferative disorders - complications (115) 115
genetic aspects (114) 114
diagnosis (110) 110
animals (109) 109
acute myeloid-leukemia (108) 108
young adult (106) 106
tumors (104) 104
tyrosine kinase jak2 (103) 103
health aspects (101) 101
survival rate (100) 100
survival (98) 98
cancer (95) 95
mortality (94) 94
myeloid metaplasia (92) 92
primary myelofibrosis - mortality (92) 92
primary myelofibrosis (90) 90
follow-up studies (88) 88
transplantation (88) 88
hemic and lymphatic diseases (85) 85
myelodysplastic syndromes (85) 85
myeloproliferative disorders - diagnosis (85) 85
chronic myeloproliferative disorders (84) 84
myeloproliferative disorders - therapy (82) 82
jak2 (81) 81
child (79) 79
myeloproliferative disorders - pathology (79) 79
myeloproliferative disorders - drug therapy (78) 78
article (75) 75
stem cells (75) 75
analysis (73) 73
patients (68) 68
risk (68) 68
therapy (68) 68
chronic myelogenous leukemia (67) 67
disease progression (67) 67
disease (66) 66
international working group (66) 66
primary myelofibrosis - genetics (66) 66
disorders (64) 64
mice (64) 64
transplantation, homologous (64) 64
chronic myelomonocytic leukemia (63) 63
hydroxyurea (63) 63
bone marrow (62) 62
myelodysplastic syndrome (62) 62
myelodysplastic syndromes - mortality (62) 62
bone marrow - pathology (60) 60
idiopathic myelofibrosis (59) 59
classification (58) 58
mutations (58) 58
hematopoietic stem cell transplantation (57) 57
risk-factors (57) 57
ruxolitinib (57) 57
abridged index medicus (56) 56
child, preschool (56) 56
gene mutations (56) 56
thrombosis - etiology (56) 56
chronic myeloid-leukemia (55) 55
stem-cell transplantation (55) 55
thrombocythemia, essential - mortality (55) 55
myeloproliferative neoplasm (54) 54
pathology (54) 54
primary myelofibrosis - therapy (54) 54
antineoplastic agents - therapeutic use (53) 53
prognostic-factors (53) 53
thrombocythemia, essential - genetics (53) 53
hematopoietic stem cells (51) 51
infant (50) 50
leukemia, myeloid, acute - mortality (49) 49
thrombocythemia, essential - complications (49) 49
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1061) 1061
German (8) 8
French (7) 7
Japanese (5) 5
Russian (3) 3
Czech (2) 2
Italian (2) 2
Chinese (1) 1
Polish (1) 1
Portuguese (1) 1
Spanish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, ISSN 0889-8588, 12/2017, Volume 31, Issue 6, pp. 1029 - 1029
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2010, Volume 5, Issue 2, p. e9258
Background: The Notch pathway is essential for proper epidermal differentiation during embryonic skin development. Moreover, skin specific loss of Notch... 
B-CELL DEVELOPMENT | HUMAN EPITHELIAL-CELLS | STEM-CELLS | IN-VITRO | MOUSE KERATINOCYTES | BIOLOGY | MICE | T-CELL | GROWTH-FACTOR | EXPRESSION | THYMIC STROMAL LYMPHOPOIETIN | Dermatitis, Atopic - genetics | Skin - metabolism | Humans | Receptor, Notch2 - genetics | Receptors, Notch - genetics | Myeloproliferative Disorders - genetics | Granulocyte Colony-Stimulating Factor - genetics | Dermatitis, Atopic - mortality | Flow Cytometry | Receptors, Cytokine - metabolism | Receptors, Cytokine - genetics | Granulocyte Colony-Stimulating Factor - metabolism | Skin - pathology | Immunoglobulins | Cytokines - metabolism | Mice, Inbred C57BL | Receptors, Notch - physiology | Mice, Transgenic | Survival Rate | Signal Transduction - genetics | Dermatitis, Atopic - physiopathology | Reverse Transcriptase Polymerase Chain Reaction | Mice, Knockout | Receptor, Notch2 - physiology | Animals | Mice, Nude | Models, Biological | Survival Analysis | Myeloproliferative Disorders - physiopathology | Signal Transduction - physiology | Mice | Skin - physiopathology | Receptor, Notch1 - genetics | Myeloproliferative Disorders - mortality | Receptor, Notch1 - physiology | Embryonic development | Psoriasis | Atopic dermatitis | Bone marrow | Transplantation | Skin | B cells | Syngeneic grafts | Pathogenesis | Bone marrow transplantation | Homeostasis | Lichen planus | Inactivation | Dermatitis | Thymus | Signal transduction | Embryogenesis | Biomedical materials | Immunology | Granulocytes | Granulocyte colony-stimulating factor | Lymphocytes | Rodents | Biocompatibility | Drug dosages | Osteopenia | Neutropenia | Spleen | Repressing | Deactivation | Cytokines | Developmental biology | Dermatology | Leukocytes (eosinophilic) | Neutrophils | Keratinocytes | Breast cancer | Gene expression | Myeloproliferative diseases | Hemopoiesis | Signaling | Thymic stromal lymphopoietin | Stem cells | Mast cells | Infiltration | Notch protein | Bone | Hematopoietic system | Mutation | Eosinophils
Journal Article
Journal Article
Journal Article